From Organs to Algorithms and Molecular Landscapes
Seems like cost (and complexity) will be rate limiting for clinical adoption since deep measurement and deep analysis now possible.
Great point. Agree that in the short term, cost and complexity would be barriers to implantation and adoption. But I think we’re nearing an inflection point where the benefits will outweigh the costs.
Seems like cost (and complexity) will be rate limiting for clinical adoption since deep measurement and deep analysis now possible.
Great point. Agree that in the short term, cost and complexity would be barriers to implantation and adoption. But I think we’re nearing an inflection point where the benefits will outweigh the costs.